+42.1%
RKT vs EMR
+62.0%
-19.9%
-50.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.8% | -0.4% | -1.3% | -1.5% |
| 7D | +6.0% | +3.1% | +2.9% | +4.0% |
| 30D | +0.7% | -3.5% | +4.2% | +3.0% |
| 3M | +11.8% | +9.8% | +2.0% | +5.5% |
| 6M | -7.6% | +10.8% | -18.4% | -13.1% |
| YTD | -28.7% | +15.9% | -44.6% | -33.9% |
| 1Y | -32.6% | +16.4% | -49.0% | -37.8% |
| 3Y | +42.1% | +62.1% | -20.0% | +3.8% |
| All | +42.1% | +62.0% | -19.9% | +3.8% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling